TransMedics Group, Inc. — Director's Dealing 2022

Jun 6, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2022-06-01

Reporting Person: Basile Edward M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-01	Stock Option (Right to Buy)	$28.12	A	13500	Acquired	2032-06-01	Common Stock (13500)	Direct

Footnotes

F1: The option vests in full on the earlier of the first anniversary of the date of grant, June 1, 2023, or the date of the following annual meeting of shareholders of the Company.